Capitalization 262.2Cr 22TCr P/E ratio 2024 *
80.6x
P/E ratio 2025 * 37.4x
Enterprise value 270.53Cr 23TCr EV / Sales 2024 *
3.36x
EV / Sales 2025 * 2.68x
Free-Float
21.82%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.40%
1 week-10.84%
Current month-12.53%
1 month-9.32%
3 months-11.41%
6 months+1.62%
Current year+3.13%
More quotes
1 week
6.88
Extreme 6.88
7.80
1 month
6.88
Extreme 6.88
8.80
Current year
5.27
Extreme 5.27
9.26
1 year
4.14
Extreme 4.135
9.26
3 years
3.82
Extreme 3.8201
47.54
5 years
3.82
Extreme 3.8201
64.22
10 years
3.82
Extreme 3.8201
64.22
More quotes
Director TitleAgeSince
Founder 53 01/11/01
Chief Executive Officer 53 25/23/25
Director of Finance/CFO 54 01/20/01
Manager TitleAgeSince
Founder 53 01/11/01
Founder 46 01/11/01
Director/Board Member 44 01/15/01
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-2.40%-10.84%+19.97%-84.99%268.65Cr
-0.05%+3.68%+25.68%-14.44%46TCr
-0.47%+0.57%+81.47%+21.83%30TCr
-1.78%+2.01%+58.84%+85.83%16TCr
-1.17%+3.71%+16.61%+8.18%9.17TCr
+1.89%+11.41%-4.95%-18.84%8.14TCr
+1.37%+8.07%+127.14%+53.59%7.23TCr
+1.77%+6.37%+76.97%-36.58%5.65TCr
+0.12%+4.84%+16.95%+58.32%3.61TCr
-2.42%-1.90%-4.63%-12.79%3.25TCr
Average -0.23%+3.91%+41.40%+6.01% 12.93TCr
Weighted average by Cap. +0.08%+5.20%+47.11%+12.40%
See all sector performances
2024 *2025 *
Net sales 80Cr 6.68TCr 88Cr 7.33TCr
Net income 4.2Cr 350.23Cr 8.5Cr 709.41Cr
Net Debt 7.14Cr 595.86Cr -27Cr -2.27TCr
More financial data * Estimated data
Logo GoodRx Holdings, Inc.
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Employees
694
More about the company
Date Price Change Volume
20/24/20 6.910 $ -2.40% 1,491,244
19/24/19 7.080 $ -3.67% 1,200,865
18/24/18 7.350 $ -3.16% 1,060,411
17/24/17 7.590 $ -1.17% 794,755
16/24/16 7.680 $ -0.90% 854,973

Delayed Quote Nasdaq, September 21, 2024 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
6.910USD
Average target price
9.556USD
Spread / Average Target
+38.29%
Consensus